tiprankstipranks
Trending News
More News >
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market

Candel Therapeutics (CADL) Ownership - Who Owns Candel Therapeutics?

Compare
319 Followers

Candel Therapeutics (CADL) Ownership Overview

18.48%15.68%13.70%5.44%46.70%
18.48% Insiders
13.70% Other Institutional Investors
5.44% ETFs
46.70% Public Companies and Individual Investors
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 34.82% of the company’s stock is owned by Institutional Investors, 18.48% is owned by Insiders, and 46.70% is owned by Public Companies and Individual Investors.
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 29.38% of the company’s stock is owned by Institutional Investors, 18.48% is owned by Insiders, and 5.44% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 17, 2025
xxxxxxxxxxxxx
$97715
Jan 17, 2025
xxxxxxxxxxxxx
$75290
Jan 17, 2025
xxxxxxxxxxxxx
$156703
Jan 17, 2025
xxxxxxxxxxxxx
$103405

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$101174
Mar 31, 2025
xxxxxxxxxxxxx
$13770117

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,544,979Institution11.07%29,665,638
4,431,832Insider8.85%23,710,301
4,127,158Insider8.24%22,080,295
2,437,189Institution4.86%13,038,961
1,605,592Institution3.20%8,589,917
1,129,501Institution2.25%6,042,830
1,017,221Institution2.03%5,442,132
370,797Institution0.74%1,983,764
225,740Insider0.45%1,207,709
219,334Institution0.44%1,173,437

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,544,979Institution11.07%29,665,638
1,129,501Institution2.25%6,042,830
370,797Institution0.74%1,983,764
219,334Institution0.44%1,173,437
192,434Institution0.38%1,029,522
120,026Institution0.24%642,139
74,895Institution0.15%400,688
66,217Institution0.13%354,261
52,183Institution0.10%279,179
17,160Institution0.03%91,806

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
866,650Institution1.73%4,255,252
712,879Institution1.42%3,813,903
489,524Institution0.98%2,403,563
245,871Institution0.49%1,315,410
140,506Institution0.28%689,884
57,171Institution0.11%305,865
41,679Institution0.08%212,980
25,919Institution0.05%127,262
16,703Institution0.03%85,352
16,238Institution0.03%132,044

FAQ

Who Owns Candel Therapeutics (CADL)?
According to the latest TipRanks data, approximately 13.70% of the company's stock is held by institutional investors, 18.48% is held by insiders, and 46.70% is held by retail investors.
    What percentage of Candel Therapeutics (CADL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 13.70% of Candel Therapeutics (CADL) stock is held by institutional investors.
      What percentage of Candel Therapeutics (CADL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 46.70% of Candel Therapeutics (CADL) stock is held by retail investors.
        Who owns the most shares of Candel Therapeutics (CADL)?
        Fidelity Select Portfolios owns the most shares of Candel Therapeutics (CADL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis